v3.20.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income:    
Revenue
Expenses:    
Research and development 20,057 20,057
General and administrative 289,811 184,896
Interest 220,439 93,370
Total expenses 530,307 298,323
Net loss $ (530,307) $ (298,323)
Loss per share:    
Basic and diluted (in dollars per share) $ (0.003) $ (0.004)
Weighted average shares outstanding, basic and diluted (in shares) 193,621,826 68,622,677

Source